Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
New oral sorbent targeting hyperkalemia; trial results to be presented at ASN. |
ZSPHARMA: Presentation: ZS 9, a Novel, First in Class Hyperkalemia Therapy: Results from a Multicenter, Double Blind, Placebo Controlled, Multiple Dose Study to Evaluate the Effects of ZS 9 in Patients with Chronic Kidney Disease and Hyperkalemia. Presenter: Principal investigator Dr. Stephen R. Ash of Indiana University. |